MetLife Investment Management’s Cassava Sciences SAVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-22,699
| Closed | -$668K | – | 2850 |
|
|
2024
Q3 | $668K | Hold |
22,699
| – | – | ﹤0.01% | 1622 |
|
|
2024
Q2 | $280K | Buy |
22,699
+2,277
| +11% | +$28.1K | ﹤0.01% | 2040 |
|
|
2024
Q1 | $414K | Hold |
20,422
| – | – | ﹤0.01% | 1783 |
|
|
2023
Q4 | $460K | Hold |
20,422
| – | – | ﹤0.01% | 1742 |
|
|
2023
Q3 | $340K | Hold |
20,422
| – | – | ﹤0.01% | 1864 |
|
|
2023
Q2 | $501K | Buy |
20,422
+683
| +3% | +$16.7K | ﹤0.01% | 1690 |
|
|
2023
Q1 | $476K | Hold |
19,739
| – | – | ﹤0.01% | 1678 |
|
|
2022
Q4 | $583K | Sell |
19,739
-981
| -5% | -$29K | ﹤0.01% | 1539 |
|
|
2022
Q3 | $867K | Hold |
20,720
| – | – | 0.01% | 1268 |
|
|
2022
Q2 | $583K | Sell |
20,720
-1,092
| -5% | -$30.7K | ﹤0.01% | 1556 |
|
|
2022
Q1 | $810K | Buy |
21,812
+8,050
| +58% | +$299K | 0.01% | 1466 |
|
|
2021
Q4 | $601K | Hold |
13,762
| – | – | ﹤0.01% | 1414 |
|
|
2021
Q3 | $854K | Hold |
13,762
| – | – | 0.01% | 1205 |
|
|
2021
Q2 | $1.18M | Buy |
13,762
+1,087
| +9% | +$92.9K | 0.01% | 1083 |
|
|
2021
Q1 | $570K | Sell |
12,675
-3,221
| -20% | -$145K | 0.01% | 1450 |
|
|
2020
Q4 | $108K | Buy |
+15,896
| New | +$108K | ﹤0.01% | 2220 |
|